Neumora Therapeutics Inc.’s stock tumbled 80% Thursday, after the clinical-stage biotech said a late-stage trial of a ...

This is independent of pre-existing depressive or anxiety symptoms ... The diagnosis of major depressive disorder is based on the patient's self-reported experiences, behavior reported ...

SPL-026 is under development for the treatment of major depressive disorder (MDD). The drug candidate is a psychedelic N,N-dimethyltryptamine (DMT) based medicine. It is administered through i ...

The changing landscape of health care during COVID-19 placed focus on increasing accessibility to mental health resources other than the emergency department (ED), with potential savings of over $ ...

If you or a loved one is struggling with anxiety or depression, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 800-662-4357 for information on ...

DENVER, Dec. 16, 2024 /PRNewswire/ -- Family Care Center has published promising new research on a groundbreaking treatment for patients with anxiety and major depressive disorder (MDD).

From 2017 to 2021, pediatric depression and anxiety rates increased by 55.6% and 31.1%, respectively. Rates were higher ...

Medically reviewed by Dakari Quimby, PhD Male postpartum depression describes when a new father experiences postpartum ...

Major depressive disorder (MDD) is a chronic and recurrent mental condition leading to huge impacts on direct and indirect personal and public medical costs. To overcome such a serious mental ...

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

Transcranial magnetic stimulation for alcohol use disorders is under investigation. Research to date suggests TMS could play ...

including major depressive disorder, anxiety disorders, PTSD, ADHD, bipolar disorders, schizophrenia, insomnia, sleep disorders, and other mood disorders. With over 6 years of experience ...